| Net Cash Provided by (Used in) Operating Activities |
$218,000,000 |
USD |
27% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$525,000,000 |
USD |
-129% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$262,000,000 |
USD |
-118% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
60,309,739 |
shares |
-1.3% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$569,000,000 |
USD |
-142% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$67,000,000 |
USD |
-90% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$31,000,000 |
USD |
-21% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,000,000 |
USD |
-50% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$422,000,000 |
USD |
1.7% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability |
$382,000,000 |
USD |
0% |
Q4 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$233,000,000 |
USD |
16% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,210,000,000 |
USD |
-40% |
Q4 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$14,980,000,000 |
USD |
10% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$62,000,000 |
USD |
13% |
Q4 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.045 |
pure |
-2.2% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$3,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$3,000,000 |
USD |
50% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$154,000,000 |
USD |
18% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$421,000,000 |
USD |
1.9% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$230,000,000 |
USD |
36% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |